Professor of Medicine, Channing Laboratory
Internal Medicine
Dr. Frank M. Sacks, MD
|
|
Give Review
Frank Sacks practices Internal Medicine. He went to medical school at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is one of the top medical schools in the US. Columbia University College of Physicians & Surgeons has a rank of 8 in research and a 52 in primary care Doctor Frank M. Sacks, MD is a published doctor. He has 100 papers published. The most current publication "Weight-loss diets and 2-y changes in circulating amino acids in 2 randomized intervention trials."
Publications
- Weight-loss diets and 2-y changes in circulating amino acids in 2 randomized intervention trials.
- Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans.
- Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.
- Predicting successful long-term weight loss from short-term weight-loss outcomes: new insights from a dynamic energy balance model (the POUNDS Lost study).
- CETP genotype and changes in lipid levels in response to weight-loss diet intervention in the POUNDS LOST and DIRECT randomized trials.
- Dietary Fat Modifies the Effects of FTO Genotype on Changes in Insulin Sensitivity.
- Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb randomized clinical trial.
- PCSK 7 Genotype Modifies Effect of a Weight-Loss Diet on 2-Year Changes of Insulin Resistance: The POUNDS LOST Trial.
- Plasma phospholipid saturated fatty acids and incident atrial fibrillation: the Cardiovascular Health Study.
- Lipoprotein(a) for Risk Assessment in Patients With Established Coronary Artery Disease.
- Variants in glucose- and circadian rhythm-related genes affect the response of energy expenditure to weight-loss diets: the POUNDS LOST Trial.
- Association Between Plasma Triglycerides and HDL-Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes: A Global Case-Control Study in 13 Cou...
- IRS1 Genotype Modulates Metabolic Syndrome Reversion in Response to 2-Year Weight-Loss Diet Intervention: The POUNDS LOST trial.
- The effects of carbohydrate, unsaturated fat, and protein intake on measures of insulin sensitivity: results from the OmniHeart trial.
- Effect of dietary composition of weight loss diets on high-sensitivity c-reactive protein: The Randomized POUNDS LOST trial.
- Plasma phospholipid long-chain Ï-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.
- Associations of plasma phospholipid and dietary alpha linolenic Acid with incident atrial fibrillation in older adults: the cardiovascular health study.
- Genetic Determinant for Amino Acid Metabolites and Changes in Body Weight and Insulin Resistance in Response to Weight-Loss Diets: The Preventing Overweight Using Nove...
- Race, Plasma Renin Activity, and Morning Blood Pressure Surge--Results From the Dietary Approaches to Stop Hypertension Trial.
- TCF7L2 genetic variants modulate the effect of dietary fat intake on changes in body composition during a weight-loss intervention.
- Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategi...
- APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial.
- Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion.
- FTO Genotype and 2-Year Change in Body Composition and Fat Distribution in Response to Weight-Loss Diets: The POUNDS LOST Trial.
- Weight-loss diets modify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in body weight, fasting glucose, and insulin resis...
- Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LO...
- Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart Disease.
- The Role of Triglycerides in Atherosclerosis.
- Circulating Long-Chain {omega}-3 Fatty Acids and Incidence of Congestive Heart Failure in Older Adults: The Cardiovascular Health Study: A Cohort Study.
- Insulin Receptor Substrate 1 Gene Variation Modifies Insulin Resistance Response to Weight-Loss Diets in a 2-Year Randomized Trial: The Preventing Overweight Using Nov...
- Complexities of plasma apolipoprotein C-III metabolism.
- HMG CoA Reduction in Patients with Average Cholesterol Concentrations.
- The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association.
- Apolipoprotein CIII induces monocyte chemoattractant protein-1 and interleukin 6 expression via Toll-like receptor 2 pathway in mouse adipocytes.
- Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial.
- Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density li...
- Combination lipid therapy in type 2 diabetes.
- Early behavioral adherence predicts short and long-term weight loss in the POUNDS LOST study.
- Dietary therapy in hypertension.
- Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial.
- Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.
- Adherence is a multi-dimensional construct in the POUNDS LOST trial.
- Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins.
- Investigation of KIF6 Trp719Arg in a case-control study of myocardial infarction: a Costa Rican population.
- Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.
- Associations between macronutrient intake and self-reported appetite and fasting levels of appetite hormones: results from the Optimal Macronutrient Intake Trial to Pr...
- The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial.
- Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates.
- After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate.
- Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
- Leapfrogging data: no shortcuts for safety or efficacy information.
- Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation.
- The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.
- Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell dysfunction.
- Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that involve apolipoproteins E and C-III.
- Major potential of diet treatment for type 2 diabetes.
- Alternatives for macronutrient intake and chronic disease: a comparison of the OmniHeart diets with popular diets and with dietary recommendations.
- Abdominal obesity and hyperglycemia mask the effect of a common APOC3 haplotype on the risk of myocardial infarction.
- Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Tr...
- Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy.
- Characteristics of the diet patterns tested in the optimal macronutrient intake trial to prevent heart disease (OmniHeart): options for a heart-healthy diet.
- Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS...
- Acceptability of sodium-reduced research diets, including the Dietary Approaches To Stop Hypertension diet, among adults with prehypertension and stage 1 hypertension.
- Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.
- Conflict of interest policy for Editors of The American Journal of Clinical Nutrition.
- Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions.
- Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-k...
- Asp92Asn polymorphism in the myeloid IgA Fc receptor is associated with myocardial infarction in two disparate populations: CARE and WOSCOPS.
- Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells.
- Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the american heart association nutrition committee.
- Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat.
- Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medic...
- Lipoprotein lipase bound to apolipoprotein B lipoproteins accelerates clearance of postprandial lipoproteins in humans.
- Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells.
- Polyunsaturated fatty acids, inflammation, and cardiovascular disease: time to widen our view of the mechanisms.
- Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
- Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke.
- Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease.
- Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists.
- Dietary phytoestrogens to prevent cardiovascular disease: early promise unfulfilled.
- Your health in the 21st century. Fine-tuning heart health.
- Effect of pravastatin on cardiovascular events in people with chronic kidney disease.
- Lessons learned from the prospective pravastatin pooling project.
- Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Hea...
- Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control.
- Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in v...
- High-intensity statin treatment for coronary heart disease.
- The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy...
- Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial.
- Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and t...
- Metabolic syndrome: epidemiology and consequences.
- A propensity score-matched cohort study of the effect of statins, mainly fluvastatin, on the occurrence of acute myocardial infarction.
- Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial.
- Clinical review 163: Cardiovascular endocrinology: Low-density lipoprotein size and cardiovascular disease: a reappraisal.
- Effect of pravastatin on intermediate-density and low-density lipoproteins containing apolipoprotein CIII in patients with diabetes mellitus.
- Sodium and blood pressure: no data dredging, please!
- LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients.
- Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease.
- Dietary fat, the Mediterranean diet, and health: reports from scientific exchanges, 1998 and 2000. Introduction.
Schools
Columbia University College of Physicians And Surgeons
Brigham and Women39s Hospital
University Of Wi Hospital and Cli
Doctors Specialties
- Dietetics
- Nutrition
- Internal Medicine
Accepted Insurances
Education
-
Brigham and Women's Hospital -
University of Wisconsin -
Columbia University College of Physicians & Surgeons
Helpful Reviews
Similar Doctors
|
|
Dr. Sarah A. Murphy, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Mark Morano, CNS
This Doctor is OpenDoctor Recommended.
|
|
|
Susan M. Cummings, MS
This Doctor is OpenDoctor Recommended.
|
|
|
Katherine L. Cerrito, RD |
|
|
Alison Forte |
|
|
Kathryn Sweeney, MS |
|
|
Carol E. Chan, RD |
|
|
Danielle A. Duggan, RD |
|
|
Lauren Ferraro, MS |
|
|
Dr. James A. Stefater III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lenny Lopez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander R. Green, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gordon D. Schiff Sr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Qaiser Shafiq, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Su Hutchinson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy S. Loo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Anshul Bhalla, MB BS
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael P. Gannon, MD |
|
|
Meghan M. Ariagno, RD |
|
|
Alexis Madej, MS |
|
|
Alice W. Ng, RD |